239 related articles for article (PubMed ID: 32788212)
1. HIV-cell membrane fusion intermediates are restricted by Serincs as revealed by cryo-electron and TIRF microscopy.
Ward AE; Kiessling V; Pornillos O; White JM; Ganser-Pornillos BK; Tamm LK
J Biol Chem; 2020 Nov; 295(45):15183-15195. PubMed ID: 32788212
[TBL] [Abstract][Full Text] [Related]
2. SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.
Sood C; Marin M; Chande A; Pizzato M; Melikyan GB
J Biol Chem; 2017 Apr; 292(14):6014-6026. PubMed ID: 28179429
[TBL] [Abstract][Full Text] [Related]
3. Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.
Beitari S; Pan Q; Finzi A; Liang C
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493821
[TBL] [Abstract][Full Text] [Related]
4. HIV fusion: Catch me if you can.
Denolly S; Cosset FL
J Biol Chem; 2020 Nov; 295(45):15196-15197. PubMed ID: 33158917
[TBL] [Abstract][Full Text] [Related]
5. Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5.
Wu Y; Olety B; Weiss ER; Popova E; Yamanaka H; Göttlinger H
mBio; 2019 Jun; 10(3):. PubMed ID: 31186327
[TBL] [Abstract][Full Text] [Related]
6. Serinc5 Restricts HIV Membrane Fusion by Altering Lipid Order and Heterogeneity in the Viral Membrane.
Ward AE; Sokovikova D; Waxham MN; Heberle FA; Levental I; Levental KR; Kiessling V; White JM; Tamm LK
ACS Infect Dis; 2023 Apr; 9(4):773-784. PubMed ID: 36946615
[TBL] [Abstract][Full Text] [Related]
7. TIM-mediated inhibition of HIV-1 release is antagonized by Nef but potentiated by SERINC proteins.
Li M; Waheed AA; Yu J; Zeng C; Chen HY; Zheng YM; Feizpour A; Reinhard BM; Gummuluru S; Lin S; Freed EO; Liu SL
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5705-5714. PubMed ID: 30842281
[TBL] [Abstract][Full Text] [Related]
8. HIV envelope tail truncation confers resistance to SERINC5 restriction.
Haider T; Snetkov X; Jolly C
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34001619
[TBL] [Abstract][Full Text] [Related]
9. Coelacanth
Ramdas P; Bhardwaj V; Singh A; Vijay N; Chande A
J Virol; 2021 Jun; 95(13):e0022921. PubMed ID: 33883219
[No Abstract] [Full Text] [Related]
10. Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry.
Leonhardt SA; Purdy MD; Grover JR; Yang Z; Poulos S; McIntire WE; Tatham EA; Erramilli SK; Nosol K; Lai KK; Ding S; Lu M; Uchil PD; Finzi A; Rein A; Kossiakoff AA; Mothes W; Yeager M
Nat Commun; 2023 Jul; 14(1):4368. PubMed ID: 37474505
[TBL] [Abstract][Full Text] [Related]
11. SERINC5 Potently Restricts Retrovirus Infection
Timilsina U; Umthong S; Lynch B; Stablewski A; Stavrou S
mBio; 2020 Jul; 11(4):. PubMed ID: 32665269
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.
Kirschman J; Qi M; Ding L; Hammonds J; Dienger-Stambaugh K; Wang JJ; Lapierre LA; Goldenring JR; Spearman P
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212940
[TBL] [Abstract][Full Text] [Related]
13. SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.
Gonzalez-Enriquez GV; Escoto-Delgadillo M; Vazquez-Valls E; Torres-Mendoza BM
J Immunol Res; 2017; 2017():1548905. PubMed ID: 29359168
[TBL] [Abstract][Full Text] [Related]
14. Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters.
Chen YC; Sood C; Marin M; Aaron J; Gratton E; Salaita K; Melikyan GB
ACS Nano; 2020 Sep; 14(9):10929-10943. PubMed ID: 32441921
[TBL] [Abstract][Full Text] [Related]
15. The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.
Trautz B; Wiedemann H; Lüchtenborg C; Pierini V; Kranich J; Glass B; Kräusslich HG; Brocker T; Pizzato M; Ruggieri A; Brügger B; Fackler OT
J Biol Chem; 2017 Aug; 292(33):13702-13713. PubMed ID: 28659343
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence Microscopy of the HIV-1 Envelope.
Carravilla P; Nieva JL; Eggeling C
Viruses; 2020 Mar; 12(3):. PubMed ID: 32245254
[TBL] [Abstract][Full Text] [Related]
17. Effect of HIV-1 Env on SERINC5 Antagonism.
Beitari S; Ding S; Pan Q; Finzi A; Liang C
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928004
[TBL] [Abstract][Full Text] [Related]
18. Correlative microscopy for 3D structural analysis of dynamic interactions.
Jun S; Zhao G; Ning J; Gibson GA; Watkins SC; Zhang P
J Vis Exp; 2013 Jun; (76):. PubMed ID: 23852318
[TBL] [Abstract][Full Text] [Related]
19. Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike.
Ozorowski G; Pallesen J; de Val N; Lyumkis D; Cottrell CA; Torres JL; Copps J; Stanfield RL; Cupo A; Pugach P; Moore JP; Wilson IA; Ward AB
Nature; 2017 Jul; 547(7663):360-363. PubMed ID: 28700571
[TBL] [Abstract][Full Text] [Related]
20. Effects of the SOS (A501C/T605C) and DS (I201C/A433C) Disulfide Bonds on HIV-1 Membrane Envelope Glycoprotein Conformation and Function.
Nguyen HT; Alsahafi N; Finzi A; Sodroski JG
J Virol; 2019 Jun; 93(12):. PubMed ID: 30944182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
